Intensive chemotherapy of acute myelogenous leukaemia
Gorman, A.; Fennelly, J.J.; O'Connell, L.G.
Journal of the Irish Medical Association 65(20): 509-513
1972
ISSN/ISBN: 0021-129X PMID: 4507652 Document Number: 55318
Document emailed within 1 workday
Related Documents
Wöhrer, S.; Rabitsch, W.; Shehata, M.; Kondo, R.; Esterbauer, H.; Streubel, B.; Sillaber, C.; Raderer, M.; Jaeger, U.; Zielinski, C.; Valent, P. 2007: Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone Anticancer Research 27(6b): 3837-3841Taguchi, H.; Kubonishi, I.; Takehara, N.; Uemura, Y.; Iwahara, Y.; Eguchi, T.; Miyagi, T.; Sugito, S.; Muneishi, H.; Tanaka, Y. 1992: Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(9): 1309-1314
Oblon, D.J.; Weiner, R.S.; Kramer, B.S.; Ross, W.; Noyes, W.D.; Boyett, J.; Kitchens, C.S. 1985: Intensive short-term chemotherapy for patients with acute myelogenous leukemia: long-term follow-up Cancer Treatment Reports 69(12): 1425-1427
Hsu, H.C.; Chiu, C.F.; Tan, T.D.; Chau, W.K.; Tseng, C.S.; Ho, C.H. 1995: Post-remission intensive consolidation with high-dose cytarabine-based chemotherapy and granulocyte colony-stimulatory factor in adults with acute myelogenous leukemia: a preliminary report Zhonghua Yi Xue Za Zhi 56(5): 305-311
Löwenberg, B. 1997: Treatment of acute myelogenous leukaemia Journal of Internal Medicine. Supplement 740: 17-22
Jaiprakash, M.P.; Antia, P.K.; Shetty, P.A. 1981: Extramedullary deposits in acute myelogenous leukaemia Indian Journal of Cancer 18(1): 51-53
Nemet, D.; Labar, B.; Bogdanić, V.; Hauptman, E.; Jaksić, B.; Minigo, H.; Sertić, D.; Mrsić, M.; Pavletić, Z.; Kovacević, J. 1989: High dose cytosine arabinoside in the treatment of adult acute myelogenous leukaemia Bone Marrow Transplantation 4(Suppl 3): 42-44
Van Rhee, F.; Lin, F.; Cross, N.C.; Reid, C.D.; Lakhani, A.K.; Szydlo, R.M.; Goldman, J.M. 1994: Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia Bone Marrow Transplantation 14(4): 609-612
George, E.; Kamarulzaman, E. 1979: Prognostic significance of morphological and cytochemical markers in adult acute myelogenous leukaemia: concepts and observations Medical Journal of Malaysia 34(2): 184-186
Carella, A.M.; Podesta, M.; Frassoni, F.; Raffo, M.R.; Pollicardo, N.; Pungolino, E.; Vimercati, R.; Sessarego, M.; Parodi, C.; Rabitti, C. 1993: Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia Bone Marrow Transplantation 12(3): 267-271
Gale, R.P.; Butturini, A. 1989: Chemotherapy versus transplantation: I. Acute myelogenous leukemia Haematologica 74(1): 1-4
Stopera, S.A.; Ray, M. 1989: Expression and distribution of aphidicolin-induced fragile sites in chronic myeloid leukaemia, acute lymphocytic leukaemia and acute myeloid leukaemia Cytobios 60(241): 103-109
Suri, R.; Kueh, Y.K.; Han, P.; Tan, Y.O. 1990: Chemotherapy of adult acute myeloid leukaemia Annals of the Academy of Medicine Singapore 19(2): 175-177
Yunus, A.B.; Sayeed, M.A.; Barua, A.; Rahman, J.; Rashid, M.A. 1997: Chemotherapy of acute myeloblastic leukaemia with DAM regimen Bangladesh Medical Research Council Bulletin 23(3): 82-86
Fülle, H.H. 1977: Induction and maintenance treatment of acute myelogenous leukemia in adults by sequential use of combination chemotherapy Medizinische Klinik 72(15): 642-649
Hsu, K.F.; Chang, C.H.; Chou, C.Y. 1995: Sinusoidal fetal heart rate pattern during chemotherapy in a pregnant woman with acute myelogenous leukemia Journal of the Formosan Medical Association 94(9): 562-565
Haas, R.J.; Belohradsky, B.; Dickerhoff, R.; Eichinger, K.; Eife, R.; Holtmann, H.; Goetz, O.; Graubner, U.; Peller, P. 1985: Active immunization against varicella of children with acute leukaemia or other malignancies on maintenance chemotherapy Postgraduate Medical Journal 61(Suppl 4): 69-72
Maslak, P.G.; Weiss, M.A.; Berman, E.; Yao, T.J.; Tyson, D.; Golde, D.W.; Scheinberg, D.A. 1996: Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia Leukemia 10(1): 32-39
Cetkovsky, P.; Koza, V.; Cepelák, V.; Vít, L. 1994: The influence of induction chemotherapy and remission status on haemostasis in patients treated for acute myeloid leukaemia Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 5(3): 349-353
Machover, D.; Schwarzenberg, L.; D'Hubert, E.; Lemaigre, G.; Caillou, B.; Tourani, J.M.; Michalski, B.; Goldschmidt, E.; Gaget, H.; De Vassal, F.; Misset, J.L.; Dorval, T.; Ribaud, P.; Jasmin, C.; Hayat, M.; Rappaport, H.; Mathé, G. 1982: Treatment of acute myeloid leukemia with a protocol combining intensive induction chemotherapy, early consolidation treatment, splenectomy and long-term maintenance chemotherapy. Preliminary study La Nouvelle Presse Medicale 11(52): 3835-3839